KAGAWA UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-02-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.ec.kagawa-u.ac.jp
Clinical Trials
59
Active:0
Completed:30
Trial Phases
4 Phases
Phase 1:3
Phase 2:2
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (56 trials with phase data)• Click on a phase to view related trials
Not Applicable
49 (87.5%)Phase 1
3 (5.4%)Phase 2
2 (3.6%)Phase 4
2 (3.6%)Hypothermia Versus Normothermia After Extracorporeal Cardiopulmonary Resuscitation for Out-of-hospital Cardiac Arrest
Not Applicable
Recruiting
- Conditions
- Out-of-hospital Cardiac Arrest (OHCA)ECMO TreatmentTemperaturePost Cardiac Arrest Syndrome
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Kagawa University
- Target Recruit Count
- 468
- Registration Number
- NCT06776549
- Locations
- 🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan
🇯🇵Asahikawa Medical University Hospital, Asahikawa, Hokkaido, Japan
🇯🇵Sapporo Medical University Hospital, Sapporo, Hokkaido, Japan
Combined 25-gauge Vitrectomy and Cataract Surgery With Toric Intraocular Lens With Idiopathic Epiretinal Membrane.
Not Applicable
- Conditions
- Epiretinal MembraneCataractCorneal Astigmatism
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Kagawa University
- Target Recruit Count
- 30
- Registration Number
- NCT02328157
- Locations
- 🇯🇵
Kagawa University Faculty of Medicine, Miki, Kagawa, Japan
Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema
Completed
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2018-03-08
- Lead Sponsor
- Kagawa University
- Target Recruit Count
- 30
- Registration Number
- NCT02329132
- Locations
- 🇯🇵
Kagawa University Faculty of Medicine, Miki, Kagawa, Japan
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
Phase 4
Recruiting
- Conditions
- Macular Disease
- Interventions
- Drug: ranibizumab, aflibercept, pegaptanib, verteporphin
- First Posted Date
- 2014-12-22
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Kagawa University
- Target Recruit Count
- 1000
- Registration Number
- NCT02321267
- Locations
- 🇯🇵
Kagawa University Faculty of Medicine, Miki, Kagawa, Japan
Measurement of the Oxygen Saturation in the Retinal Vessels With Oxymap
- Conditions
- Chorioretinal Disorders in Diseases Classified Elsewhere
- First Posted Date
- 2014-12-17
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Kagawa University
- Target Recruit Count
- 300
- Registration Number
- NCT02318641
- Locations
- 🇯🇵
Kagawa University Faculty of Medicine, Miki, Kagawa, Japan
- Prev
- 1
- 2
- Next
News
No news found